C World Wide Group Holding A Exelixis, Inc. Transaction History

C World Wide Group Holding A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$19.6 - $24.76 $263,541 - $332,922	-13,446 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$13.65 - $21.8 $4,709 - $7,521	-345 Reduced 2.5%	13,446 $264,000
Q3 2018 Nov 05, 2018	BUY	$15.87 - $22.4 $31,311 - $44,195	1,973 Added 16.69%	13,791 $244,000
Q2 2018 Aug 03, 2018	SELL	$18.56 - $22.45 $5.48 Million - $6.63 Million	-295,457 Reduced 96.15%	11,818 $254,000
Q1 2018 May 03, 2018	SELL	$22.15 - $31.89 $1 Million - $1.44 Million	-45,233 Reduced 12.83%	307,275 $6.81 Million
Q4 2017 Feb 07, 2018	BUY	$24.23 - $30.93 $1.65 Million - $2.1 Million	67,920 Added 23.87%	352,508 $10.7 Million
Q3 2017 Nov 06, 2017	BUY	$23.35 - $29.24 $6.65 Million - $8.32 Million	284,588	284,588 $6.9 Million

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.